Melissa Rodríguez
- Toxicology top 1%
- Hematology top 10%
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 3
-
- Protein Degradation and Inhibitors 7
- Histone Deacetylase Inhibitors Research 3
-
- Cancer Treatment and Pharmacology 2
-
- Neuroendocrine Tumor Research Advances 3
-
- Advanced Breast Cancer Therapies 2
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Mingyao LiuYing WangSung‐Gook ChoTingfang YiGautam SethiXiufeng PangBharat B. AggarwalZhengfang Yi
- Partner nations
- United StatesChina
In The Last Decade
Melissa Rodríguez
20 papers receiving 681 citations
Peers
Comparison fields: 5 of 73
- Toxicology 156
- Complementary and alternative medicine 208
- Hematology 118
- Molecular Biology 382
- Oncology 143
Countries citing papers authored by Melissa Rodríguez
This map shows the geographic impact of Melissa Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Rodríguez more than expected).
Fields of papers citing papers by Melissa Rodríguez
This network shows the impact of papers produced by Melissa Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Rodríguez. The network helps show where Melissa Rodríguez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Melissa Rodríguez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 16 | |
| 7 | 2018 | 1 | |
| 8 | 2017 | 28 | |
| 9 | 2017 | 26 | |
| 10 | 2017 | 9 | |
| 11 | 2016 | 2 | |
| 12 | 2014 | 155 | |
| 13 | 2014 | 9 | |
| 14 | 2014 | 1 | |
| 15 | 2014 | 1 | |
| 16 | 2013 | 58 | |
| 17 | 2013 | 1 | |
| 18 | 2013 | 1 | |
| 19 | 2011 | 41 | |
| 20 | 2011 | 32 |
About Melissa Rodríguez
Melissa Rodríguez is a scholar working on Hematology, Family Practice and Toxicology, having authored 23 papers that have together received 688 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (7 papers), Neuroendocrine Tumor Research Advances (3 papers), Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Advanced Breast Cancer Therapies (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Toxicology (156 citations), Complementary and alternative medicine (208 citations) and Hematology (118 citations). Melissa Rodríguez has collaborated with scholars based in United States and China. Frequent co-authors include Mingyao Liu, Ying Wang, Sung‐Gook Cho, Tingfang Yi, Gautam Sethi, Xiufeng Pang, Bharat B. Aggarwal, Zhengfang Yi, Kunrong Tan and Dali Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.